Rahul Gosain

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Rahul Gosain
Jun 1, 2025, 05:25 | Blog
Jasmine Kamboj: Excellent Talk by Colleagues at ASCO25
Jasmine Kamboj, Medical Oncologist and Hematologist at the Mayo Clinic, posted on LinkedIn: "Excellent talk…
May 30, 2025, 12:29 | Opinion
Supriya Peshin: Don't Miss the Powerful Session with Rami Manochakian at ASCO 2025
Supriya Peshin, Visiting Resident in Hematology and Oncology at MD Anderson Cancer Center, shared a…
May 9, 2025, 14:01 | Blog
Meet the ASCO25 Featured Voices
Each year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together the brightest…
Apr 22, 2025, 09:40 | Blog
Devika Das: The HER2 diagnostic and treatment landscape in NSCLC
Devika Das, Associate Professor of Medicine at the University of Florida College of Medicine, shared a…
Apr 16, 2025, 08:02 | Blog
Matthew Kurian: I’m honored to be joining The Oncology Brothers to interview giants within the breast cancer field
Matthew Kurian, Physician at St. Elizabeth Healthcare and Assistant Professor of Medicine at the University…
Apr 4, 2025, 07:37 | Blog
Rahul Gosain: Less than 2 months to ASCO25
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Feb 1, 2025, 18:04 | Blog
Rahul Gosain: Discussing the recent Sub-cutaneous approval of Nivo with Saby George
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post on LinkedIn: "Nivo…
Jan 14, 2025, 05:38 | Blog
Rahul Gosain: Treatment options for Intermediate HCC with Maria Reig and Emil Cohen
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Jan 13, 2025, 10:18 | Blog
SABCS24 Highlights with Laura Huppert - Oncology Brothers
Oncology Brothers shared a post on X: “SABCS24 Part 1: Highlights with Laura Huppert. INSEMA…
Jan 11, 2025, 14:29 | Blog
Matthew Kurian: Highlights from San Antonio Breast Cancer Symposium 2024
Matthew Kurian, Assistant Professor of Medicine at the University of Kentucky College of Medicine, shared…
Jan 9, 2025, 12:14 | Blog
Rahul Gosain: Myeloma Highlights with Robert Orlowski from ASH24
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Jan 5, 2025, 18:26 | Insight
Rahul Gosain: GISeries with Shubham Pant
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Jan 5, 2025, 16:05 | Blog
How the data from GI25 will reinforce our practice - Oncology Brothers
Oncology Brothers shared a post on X: "Going to GI25? Let’s discuss the current SoC…
Dec 27, 2024, 17:35 | Blog
Rahul Gosain: CLL Highlights with John Allan
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Dec 23, 2024, 15:20 | Blog
Rahul Gosain: CAR-T Toxicity Check - From Approval to Practice, Managing Side Effects of CAR-T Therapy
Rahul Gosain shared on LinkedIn: "This is the table we’ve used (indications, common AEs, and blackbox…
Dec 23, 2024, 14:07 | Blog
Rahul Gosain: Toxicity Check on Chimeric Antigen Receptor T-Cell Therapy
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Dec 15, 2024, 10:54 | Blog
Rahul Gosain: Hepatocellular Cancer - 2nd line treatment and when to switch
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Dec 13, 2024, 14:02 | Blog
Matthew Kurian: Day 2 at SABCS was one for the books
Matthew Kurian, Assistant Professor of medicine at the University of Kentucky College of Medicine, shared…
Dec 13, 2024, 12:36 | Insight
Jasmin Hundal: Day 2 at the San Antonio Breast Cancer Symposium was packed with insights
Jasmin Hundal, Hematology Oncology Fellow at Cleveland Clinic, shared a post on LinkedIn: “Day 2…
Dec 11, 2024, 17:38 | Blog
SABCS24 Day 1 Highlights by Oncology Brothers
Oncology Brothers shared a post on X: "SABCS24 Day 1 Highlights CommunityOnc: FDA Oncology Reviews recent…
Nov 30, 2024, 17:26 | Blog
Rahul Gosain: Hepatocellular Cancer series - Unresectable HCC with Rachna Shroff
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Nov 20, 2024, 19:12 | Blog
Rahul Gosain: Role of diet and exercise in cancer with Neil Iyengar
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Nov 15, 2024, 16:41 | Blog
Rahul Gosain: Current treatment landscape for NET with Pamela Kunz
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Nov 10, 2024, 02:39 | Blog
Rahul Gosain: Palliative Care with Janet Abrahm and Ishwaria Subbiah
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Nov 2, 2024, 19:53 | Blog
Rahul Gosain: The current treatment landscape/algorithm for Ovarian Cancer with Martina Murphy
Rahul Gosain, Co-Host of the Oncology Brothers podcast, shared on LinkedIn: "Gynecological Oncology: with Martina…
Oct 25, 2024, 18:09 | Blog
Rahul Gosain: The current treatment landscape Endometrial Cancer with Shannon Westin
Rahul Gosain, Con- Host of the Oncology Brothers podcast, shared on LinkedIn: "Gynecological Oncology: with…
Oct 23, 2024, 14:12 | Insight
Rahul Gosain: The FDA approval of Tarlatama for SCLC with Misty Shields
Rahul Gosain, Con- Host of the Oncology Brothers podcast, shared on LinkedIn: “LungCancer: Here we…
Oct 21, 2024, 13:21 | Blog
Rahul Gosain: US FDA approval of Durvalumab for resectable NSCLC with Mara Antonoff and Sandip Patel
Rahul Gosain shared a post on LinkedIn: ''Lung Cancer: We speak about the US FDA…
Oct 17, 2024, 15:52 | Blog
Oncology Brothers: Last 4 weeks in Lung Cancer
Oncology Brothers shared a post on X: "Last 4 weeks in Lung Cancer: 1. PR:…
Oct 17, 2024, 14:28 | Blog
Rahul Gosain: The FDA approval of Axatilimab and latest advancements in GVHD with Shernan Holtan
Rahul Gosain posted on LinkedIn: "Hematology: Here Rohit Gosain and I the FDA approval of Axatilimab…
Oct 13, 2024, 11:05 | Insight
Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology - JCO Oncology Practice
JCO Oncology Practice shared a post on X: "Guide to Understanding and Supporting International Medical Graduates…
Oct 11, 2024, 19:53 | Blog
Rahul Gosain: GI Malignancy Highlights from ESMO24
Rahul Gosain shared a post about GI Malignancy Highlights. Read his post on LinkedIn below:…
Oct 6, 2024, 12:55 | Blog
Rahul Gosain: GU Malignancy Highlights from ESMO24 with Petros Grivas
Rahul Gosain shared on LinkedIn: "GU Malignancy Highlights from ESMO24 with Petros Grivas: - NIAGARA…
Sep 28, 2024, 07:02 | Blog
Rahul Gosain: Osimertinib now FDA approved after LAURA Phase III study
Rahul Gosain shared the following on LinkedIn: “Osimertinib now FDA approved based off LAURA: Ph III,…
Sep 24, 2024, 00:05 | Blog
Rahul Gosain: Amivantamab and Chemo now FDA approved in 2L mEGFR NSCLC after Osimertinib
Rahul Gosain posted on LinkedIn: "Amivantamab and Chemo now FDA approved in 2L mEGFR NSCLC…
Sep 23, 2024, 09:39 | Blog
Rahul Gosain: Lung Cancer Highlights from WCLC24 with Gilberto Lopes
Rahul Gosain shared on LinkedIn: “Lung Cancer Highlights from WCLC24 with GILBERTO de lima LOPES…
Sep 6, 2024, 13:33 | Insight
Note of key abstracts from ESMO24 suggested by Rahul Gosain
Rahul Gosain shared on LinkedIn: “1 week to ESMO24, here is a of key abstracts…
Sep 1, 2024, 07:58 | Insight
Rahul Gosain: The current SoC/landscape for CML with Jorge Eduardo Cortes
Rahul Gosain shared on LinkedIn: “Hematology: with Jorge Eduardo Cortes we discuss the current SoC/landscape…
Aug 27, 2024, 19:48 | Blog
Incorporating Palliative Care program in Radiation Oncology
Anish Butala shared a post on LinkedIn by Penn Medicine Radiation Oncology, adding: "Thrilled to…
Aug 25, 2024, 17:04 | Blog
Rahul Gosain: Current SoC/landscape for Follicular and Mantle Cell Lymphoma with Pallawi Torka
Rahul Gosain shared on LinkedIn: “Hematology: with Pallawi Torka we discuss the current SoC/landscape for…
Aug 19, 2024, 10:15 | Blog
Eric Singhi: Can’t-miss Oncology Brothers' LIVE event at WCLC24
Eric Singhi shared a post on X by Oncology Brothers, adding: "Can’t-miss Oncology Brothers' LIVE…
Aug 18, 2024, 12:16 | Blog
Rahul Gosain: Discussing the current SoC/landscape for DLBCL with Casulo Carla
Rahul Gosain shared on LinkedIn: "Hematology: with Casulo Carla we discuss the current SoC/landscape for…
Aug 11, 2024, 12:43 | Blog
Oncology Brothers: Melanoma Treatment Algorithm with Allison Betof Warner
Rahul Gosain posted on LinkedIn: "Melanoma: with Allison Betof Warner we the SoC for early, locally…
Aug 6, 2024, 16:58 | Blog
Rahul Gosain: Let’s cure cancer and save hearts with Susan Dent
Rahul Gosain, Director of Regional Infusion Services and Medical Director  at Wilmot Cancer Institute, shared…
Aug 4, 2024, 06:02 | Blog
Rahul Gosain: With Patrick Forde we discuss the SoC for early and locally advanced NSCLC
Rahul Gosain shared on LinkedIn: "Lung Series: with Patrick Forde we discuss the SoC for…
Aug 1, 2024, 13:27 | Blog
Rahul Gosain: How will the data from WCLC24 impacts our day to day clinical practice
Rahul Gosain shared a post on LinkedIn: "WCLC24 ~5 weeks away! Let discuss the current…
Jul 11, 2024, 13:02 | Blog
Eric Singhi: Clinical updates for patients with small cell lung cancer
Eric Singhi shared a post by Oncology Brothers on X, adding: "Always a great time…
Jun 28, 2024, 10:17 | Blog
Rahul Gosain: GI Malignancy Highlights from ASCO24 with Dr. Mark Lewis
Rahul Gosain shared a post on LinkedIn:    . “GI Malignancy Highlights from ASCO24 w/…
Jun 27, 2024, 14:30 | Blog
2024 Upstate Cancer Symposium
Yael Waknine, Medical Director of Oncology Continuing Education and Integrity, shared a post on LinkedIn: …
Jun 27, 2024, 05:29 | Blog
Chandler Park: An honor to co-host with Cathy Eng for the ASCO24 Nashville review
Chandler Park shared on LinkedIn:     . “That was FUN! It was an honor to…
Jun 24, 2024, 07:29 | Blog
Rahul Gosain: GU Malignancy Highlights from ASCO24 with Toni Choueiri
Rahul Gosain shared a post on LinkedIn: "GU (Genitourinary) Malignancy Highlights from ASCO24 (American Society…
Jun 21, 2024, 14:07 | Blog
Rahul Gosain: Breast Cancer Highlights from ASCO24 with Erika Hamilton
Rahul Gosain shared on LinkedIn:                . "Breast Cancer…
Jun 14, 2024, 05:01 | Insight
Mark Doolan: Our NoeticInsight team with Illuminate Health kicked off a series of meetings at ASCO24
Mark Doolan, Senior Vice President and Managing Director at NoeticInsight, shared on LinkedIn: “What a…
May 28, 2024, 07:58 | Blog
Rahul Gosain: Recap ASCO 23 plenary discussion, importance of MultiD approach, as you get ready for ASCO 24
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared on LinkedIn: “GI Series: As…
May 24, 2024, 14:39 | Insight
Rahul Gosain: Rohit Gosain and I are thrilled and honored to be selected as ASCO24 Featured Voice
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post by American Society…
May 22, 2024, 03:21 | Insight
Rahul Gosain: HemeSeries, with Naveen Pemmaraju we discuss treatment options and current landscape of Myelofibrosis
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared on LinkedIn: “HemeSeries: with Naveen…
May 15, 2024, 14:51 | Blog
Rahul Gosain: HemeSeries with Samer Al Hadidi for Relapsed/Refractory Multiple Myeloma
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared on LinkedIn: "HemeSeries: with Samer…
May 12, 2024, 07:53 | Insight
Rahul Gosain: Multidisciplinary approach in treating GISM HCC
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post on LinkedIn: “GI…
May 2, 2024, 09:25 | Blog
Rahul Gosain: HemeSeries with Nitin Jain
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post on LinkedIn: "HemeSeries:…
Apr 29, 2024, 07:58 | Blog
Rahul Gosain: FDA approval of Fruquintinib from FRESCO2 and how it fits in our Rx paradigm with N. Arvind Dasari
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 27, 2024, 11:47 | Blog
Dive deep into the world of lung cancer biomarker testing with Bruna Pellini and Semir Vranić - Precision Oncology CONNECT
Precision Oncology CONNECT shared a post on LinkedIn: “Dive deep into the world of lung…
Apr 16, 2024, 01:15 | Blog
Rahul Gosain: Colon cancer algorithm, with Aparna Parikh to reiterate the current landscape
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 8, 2024, 16:01 | Drugs
Rahul Gosain: Trastuzumab Deruxtecan now is FDA approved, Based on DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 3, 2024, 06:22 | Career
Rahul Gosain: I’m happy to share that I’ve completed my Master of Business Administration in Helathcare, Tech, and Leadership at The Johns Hopkins University - Carey Business School!
Jan 30, 2024, 16:57 | Blog
Daniel Stover: Honored to have the opportunity to review some high impact abstracts with the amazing Onc Brothers
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared a…
Dec 24, 2023, 18:13 | Insight
Oncology Brothers: ASH23 Myeloma Highlights with Jens Hillengass:
Oncology Brothers shared on their X/Twitter page: "ASH23 Myeloma Highlights with Jens Hillengass. - PERSEUS…
Nov 10, 2023, 23:38 | Blog
Rahul Gosain: ESMO23 Breast Cancer Highlights with Erika Hamilton
Rahul Gosain, Medical Director & Director of Regional Infusion Services, made the following post on…
Oct 8, 2023, 17:42 | Insight
Rahul Gosain: Less than 3 weeks to ESMO23, here is a list of key abstracts for general oncology that could change our SoC!
Quoting Rahul Gosain, Medical Director and Director of Regional Infusion Services at the Wilmot Cancer…
All: 68 Posts: 1 - 100
Special Coverage